| Income Statement |
| Total Revenue | 2.35M |
|
| Revenues (USD) | 2.35M |
| Cost of Revenue | 2.30M |
| Gross Profit | 47.00K |
| Operating Expenses | 6.42M |
| Research and Development Expense | 691.00K |
| Selling, General and Administrative Expense | 5.73M |
| Operating Income | -6.37M |
| Interest Expense | 292.00K |
| Income Tax Expense | 36.00K |
| Net Income | -6.70M |
| Net Income Common Stock | -6.70M |
| Net Income Common Stock (USD) | -6.70M |
| Consolidated Income | -6.70M |
| Earnings per Basic Share | -0.41 |
| Earnings per Basic Share (USD) | -0.41 |
| Earnings per Diluted Share | -0.41 |
| Earning Before Interest & Taxes (EBIT) | -6.37M |
| Earning Before Interest & Taxes (USD) | -6.37M |
| Weighted Average Shares | 16.99M |
| Weighted Average Shares Diluted | 16.99M |
| Balance Sheet |
| Cash and Equivalents | 3.76M |
| Cash and Equivalents (USD) | 3.76M |
| Trade and Non-Trade Receivables | 1.70M |
| Current Assets | 5.80M |
| Property, Plant & Equipment Net | 89.00K |
| Total Assets | 5.89M |
| Debt Current | 4.27M |
| Total Debt | 10.15M |
| Current Liabilities | 10.25M |
| Debt Non-Current | 5.88M |
| Total Liabilities | 16.13M |
| Accumulated Retained Earnings (Deficit) | -146.08M |
| Accumulated Other Comprehensive Income | -97.00K |
| Shareholders Equity | -14.97M |
| Shareholders Equity (USD) | -14.97M |
| Assets Non-Current | 89.00K |
| Total Debt (USD) | 10.15M |
| Deferred Revenue | 343.00K |
| Liabilities Non-Current | 5.88M |
| Trade and Non-Trade Payables | 3.20M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 10.00K |
| Net Cash Flow from Financing | 7.61M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.16M |
| Capital Expenditure | -11.00K |
| Issuance (Purchase) of Equity Shares | 3.23M |
| Issuance (Repayment) of Debt Securities | 1.95M |
| Net Cash Flow from Investing | -11.00K |
| Net Cash Flow from Operations | -4.41M |
| Effect of Exchange Rate Changes on Cash | -27.00K |
| Share Based Compensation | 203.00K |